| Literature DB >> 26334995 |
Liang Song1, Jueqi Yao2, Zhijing He3, Bin Xu4.
Abstract
BACKGROUND: Despite of numerous studies on periodontitis, the mechanism underlying the progression of periodontitis still remains largely unknown. This study aimed to have an expression profiling comparison between periodontitis and normal control and to identify more candidate genes involved in periodontitis and to gain more insights into the molecular mechanisms of periodontitis progression.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26334995 PMCID: PMC4559289 DOI: 10.1186/s12903-015-0086-7
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
The functional analysis of the DEGs
| Category | GO ID | Name | Count |
|
|---|---|---|---|---|
| A: the top 5 GO terms of the up-regulated DEGs | ||||
| BP | GO:0001775 | cell activation | 68 | <1.00E-16 |
| BP | GO:0002253 | activation of immune response | 48 | <1.00E-16 |
| BP | GO:0002376 | immune system process | 165 | <1.00E-16 |
| BP | GO:0002682 | regulation of immune system process | 94 | <1.00E-16 |
| BP | GO:0002684 | positive regulation of immune system process | 73 | <1.00E-16 |
| CC | GO:0005576 | extracellular region | 138 | <1.00E-16 |
| CC | GO:0005615 | extracellular space | 70 | <1.00E-16 |
| CC | GO:0044421 | extracellular region part | 86 | <1.00E-16 |
| CC | GO:0071944 | cell periphery | 191 | 2.64E-14 |
| CC | GO:0005886 | plasma membrane | 186 | 1.49E-13 |
| MF | GO:0008009 | chemokine activity | 10 | 2.35E-07 |
| MF | GO:0003823 | antigen binding | 12 | 4.64E-07 |
| MF | GO:0032403 | protein complex binding | 26 | 4.85E-07 |
| MF | GO:0042379 | chemokine receptor binding | 10 | 1.11E-06 |
| MF | GO:0005178 | integrin binding | 12 | 1.41E-06 |
| B: the top 5 GO terms of the down-regulated DEGs | ||||
| BP | GO:0043588 | skin development | 311 | 2.33E-14 |
| BP | GO:0008544 | epidermis development | 280 | 1.18E-12 |
| BP | GO:0030216 | keratinocyte differentiation | 108 | 1.09E-09 |
| BP | GO:0009913 | epidermal cell differentiation | 154 | 1.01E-08 |
| BP | GO:0009888 | tissue development | 1479 | 2.09E-08 |
| CC | GO:0030057 | desmosome | 22 | 5.73E-06 |
| CC | GO:0005882 | intermediate filament | 191 | 2.33E-05 |
| CC | GO:0045111 | intermediate filament cytoskeleton | 231 | 2.76E-05 |
| CC | GO:0045095 | keratin filament | 93 | 0.00096928 |
| CC | GO:0005911 | cell-cell junction | 297 | 0.00108577 |
| MF | GO:0005198 | structural molecule activity | 627 | 2.89E-05 |
| MF | GO:0005200 | structural constituent of cytoskeleton | 94 | 0.00104197 |
| MF | GO:0016755 | transferase activity, transferring amino-acyl groups | 24 | 0.003031659 |
| MF | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 25 | 0.003414279 |
| MF | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 26 | 0.003825148 |
MF molecular function, BP biological process, CC cell component
The pathway enrichment analysis of the DEGs
| KEGG ID | Name | Count |
|
|---|---|---|---|
| A: the top 10 enriched pathways of the up-regulated DEGs | |||
| 5150 | Staphylococcus aureus infection | 55 | 4.40E-12 |
| 5144 | Malaria | 51 | 2.12E-09 |
| 4060 | Cytokine-cytokine receptor interaction | 265 | 2.39E-08 |
| 4141 | Protein processing in endoplasmic reticulum | 165 | 5.11E-07 |
| 4640 | Hematopoietic cell lineage | 88 | 5.53E-07 |
| 5323 | Rheumatoid arthritis | 91 | 8.66E-07 |
| 5140 | Leishmaniasis | 72 | 1.64E-06 |
| 4670 | Leukocyte transendothelial migration | 116 | 4.30E-06 |
| 4514 | Cell adhesion molecules (CAMs) | 133 | 6.18E-06 |
| 4062 | Chemokine signaling pathway | 189 | 1.71E-05 |
| B: the top 10 enriched pathways of the down-regulated DEGs | |||
| 590 | Arachidonic acid metabolism | 59 | 0.002776062 |
| 980 | Metabolism of xenobiotics by cytochrome P450 | 71 | 0.005420335 |
| 982 | Drug metabolism - cytochrome P450 | 73 | 0.005982341 |
| 350 | Tyrosine metabolism | 41 | 0.007842248 |
| 1100 | Metabolic pathways | 1130 | 0.012102847 |
| 5144 | Malaria | 51 | 0.014274311 |
| 5014 | Amyotrophic lateral sclerosis (ALS) | 53 | 0.015832167 |
| 4145 | Phagosome | 153 | 0.018215247 |
| 4916 | Melanogenesis | 101 | 0.018240082 |
| 563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 25 | 0.025692313 |
| 830 | Retinol metabolism | 64 | 0.026060907 |
| 591 | Linoleic acid metabolism | 30 | 0.036083866 |
Fig. 1Protein-protein interaction (PPI) network of the differentially expressed genes (DEGs). Red nodes stand for the up-regulated DEGs while green nodes stand for the down-regulated genes
Fig. 2Analysis of the PPI network.A, topological analysis of the degrees of the DEGs in the PPI network. Horizontal axis stands for the degree of one DEG and vertical axis stands for the number of nodes. B, module 1 of DEGs from PPI network. C, module 2 of DEGs from PPI network. D, module 3 of DEGs from PPI network. Red nodes stand for the up-regulated DEGs while green nodes stand for the down-regulated genes. The size of one node is proportional to the degree of this gene
The top 5 DEGs with higher degrees in the selected modules
| Module | Gene | Expression changes | Degree |
|---|---|---|---|
| module 1 | CTSS | up | 20 |
| CCL5 | up | 19 | |
| PLEK | up | 19 | |
| CCR1 | up | 19 | |
| FPR1 | up | 19 | |
| Module 2 | IL6 | up | 17 |
| LCK | up | 14 | |
| FCER1G | up | 13 | |
| CD19 | up | 13 | |
| CSF1R | up | 13 | |
| Module 3 | IL8 | up | 13 |
| IL1B | up | 12 | |
| MMP9 | up | 11 | |
| PTGS2 | up | 11 | |
| PLAT | up | 10 |
Fig. 3Regulatory network of the transcription factors-DEGs. Diamond represents the transcription factor while the circle represents the DEG. Red color stands for up-regulated expression while green color stands for down-regulated expression